Semaglutide

WHAT SEMAGLUTIDE IS?

Semaglutide is a safe medicine for type 2 diabetes that has FDA approval. It is a member of the pharmacological group known as glucagon-like peptide-1 (GLP-1) receptor agonists. In recent years, semaglutide has become more well-known as a medication for type 2 diabetes and for helping people who are overweight or obese lose weight while also managing certain medical disorders. Semaglutide lowers blood sugar levels in diabetics by boosting the production of insulin and inhibiting the release of glucagon. Semaglutide has been authorised for use as a weight reduction drug in addition to its usage in diabetes.

FDA APPROVED MEDICATION

Food and Drug Administration (FDA) recently authorised semaglutide as a weight-loss drug. It functions by decreasing hunger and enhancing feelings of fullness, which causes a decrease in food consumption and eventual weight loss.

ADVANTAGES OF SEMAGLUTIDE

Semaglutide has a number of advantages when taken as a weight-loss medicine, including:

• Weight loss that is considerable: According to clinical trials, semaglutide can cause weight reduction that is significant, with individuals shedding an average of 15% of their body weight over the course of 68 weeks.
• Reducing the likelihood of developing type 2 diabetes, lowering blood pressure, and enhancing cholesterol levels are just a few of the health outcomes that may be improved by losing weight.
• Increased satiety: Semaglutide works by making you feel more satisfied and suppressing your appetite, which can help you eat less and lose weight.
• Convenience: Semaglutide is injected once per week, making it a practical therapy choice for patients who have trouble adhering to a daily prescription schedule.

HOW DOES IT WORK?

By Lowering caloric intake, semaglutide lowers total body weight and fatty tissue mass. This method comprises enhanced regulation of food intake and a decrease in food cravings, as well as a general decrease in appetite, an increase in satiety signals, and a decrease in hunger signals. Also decreased, presumably as a result of weight reduction, is insulin resistance. Semaglutide also lessens a person's inclination for meals heavy in fat. Semaglutide has been demonstrated in animal experiments to be absorbed by particular brain regions, which increases critical satiety signals and attenuates key hunger signals. Semaglutide stimulates satiety-related neurons and decreases hunger-related neurons via acting on discrete regions of brain tissue.

SUPPORT TO HEALTH

Semaglutide Decreased inflammation, lowered systolic blood pressure, and improved plasma lipids in clinical investigations. Semaglutide reduces atherosclerosis in animal experiments by halting the growth of aortic plaques and lowering inflammation inside the plaques. Semaglutide decreased calorie intake throughout three daily meals by 35% when compared to placebo. Semaglutide decreased fasting triglycerides and VLDL cholesterol by 12% and 21%, respectively, as compared to placebo. There was a more than 40% reduction in the postprandial rises in triglycerides and VLDL cholesterol in response to a high-fat meal. After the initial dosage, semaglutide decreased blood glucose levels.

SAFETY

Semaglutide Has been thoroughly examined in weight reduction clinical studies and has been shown to be usually well-tolerated. Like every medicine, semaglutide has possible dangers and negative effects. Semaglutide frequently causes adverse symptoms such as nausea, vomiting, diarrhoea, constipation, and stomach discomfort. The majority of these side effects are minor, and they usually get better with time.

WHY DRIADA?

Semaglutide, which is marketed under the brand name Ozempic, is a very well-liked medication. We also offer you the same medicine under our own brand, which you may buy at a reasonable price and without a doctor's prescription.

HOW DO I USE IT?

For Weight loss, 2.4 mg of semaglutide once per week is advised. Starting semaglutide dose for weight reduction is 0.25 mg once each week for four weeks. Your body will have an opportunity to adjust to the medication by doing this. You raise the dosage to 0.5 mg in the second month. Up to 1 mg is taken during the third month, 1.7 mg during the fourth, and 2.4 mg each week during the fifth. In general, it may be advised to start with a lower dose and gradually increase it over time to reduce the chance of negative effects. Semaglutide dosage for weight reduction, however, can vary depending on a number of variables, such as your general health, medical history, and any other drugs you may be taking. The patient self-administers semaglutide once per week as a subcutaneous injection (injected beneath the skin) for weight reduction.